Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT02476201
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 105 participants
- Sponsor
- Registry
-
NCT02476201
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT02476201. Allocation not applicable; no masking; primary purpose treatment. Start 2016-02 (actual); primary completion 2019-02-13 (actual). Results posted on 2020-08-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)
- Acronym
- QUARTO_III
- Condition
- Heart Failure
- Intervention (Device)
- MPP ON
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct02476201- Content hash
1322b84878d23b6471aaf307fd2072212d4720d76867a6506dafc04b2e8404dc